M Kasai

Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study

Tomofumi Igarashi, Yukio Kobayashi, Michinori Ogura et al. · Annals of Oncology · 2002 · 138 citations · Full text

Hematological Malignancy, Indolent B-cell Lymphoma, Progression-free Survival +10

Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.

Masahiro Imamura, Satoshi Hashino, Hirohito Kobayashi et al. · 中国科教创新导刊 · 1994 · 131 citations

Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome

K Nakai, Yoshinobu Kanda, S Fukuhara et al. · Leukemia · 2005 · 119 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +9

The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease

Junji Tanaka, Masahiro Imamura, M Kasai et al. · Bone Marrow Transplantation · 1997 · 75 citations

Inflammation, Type 1, Cell Therapy +12

Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate

Yoshinobu Kanda, Koji Izutsu, Hisamaru Hirai et al. · Leukemia · 2004 · 64 citations

Graft-versus-host Disease, Transplantation, Marrow Transplantation +8